Table 2.
Laboratory test results of the plaque enhancement groups.
| Total (n = 69) | No/Mild enhancement group (n = 40) | Obvious enhancement group (n = 29) | p value | |
|---|---|---|---|---|
| Leukocyte (109/L) | 6.40 (5.22–8.10) | 5.60 (5.02–8.04) | 7.01 (5.81–8.13) | 0.081 |
| Neutrophil (109/L) | 3.87 (3.13–5.22) | 3.81 (2.80–5.22) | 4.19 (3.37–5.29) | 0.458 |
| Lymphocyte (109/L) | 1.67 (1.35–2.06) | 1.63 (1.22–2.02) | 1.70 (1.48–2.28) | 0.141 |
| Monocyte (109/L) | 0.43 (0.32–0.56) | 0.37 (0.30–0.53) | 0.44 (0.38–0.58) | 0.118 |
| Platelet (109/L) | 212 (175.5–256.0) | 204 (167.8–256.5) | 222 (191.5–263.5) | 0.157 |
| Cholesterol (mmol/L) | 3.49 (3.13–4.57) | 3.43 (3.13–4.22) | 3.89 (3.05–4.78) | 0.408 |
| Triglyceride (mmol/L) | 1.40 (1.04–1.78) | 1.26 (0.97–1.63) | 1.50 (1.26–1.89) | 0.048* |
| HDL (mmol/L) | 1.02 (0.21) | 1.05 (0.20) | 0.98 (0.23) | 0.191 |
| LDL (mmol/L) | 2.17 (1.90–2.90) | 2.07 (1.90–2.54) | 2.37 (1.93–3.08) | 0.204 |
| VLDL (mmol/L) | 0.36 (0.18–0.53) | 0.31 (0.14–0.40) | 0.51 (0.30–0.60) | 0.004* |
| Apolipoprotein A1 (g/L) | 1.15 (1.05–1.29) | 1.15 (1.07–1.31) | 1.15 (0.91–1.23) | 0.334 |
| Apolipoprotein B (g/L) | 0.82 (0.25) | 0.77 (0.23) | 0.89 (0.26) | 0.051 |
| CRP a (nmol/L) | 3.30 (2.12–5.74) | 3.25 (0.54–3.30) | 6.44 (3.19–20.78) | 0.023* |
| ESR b (mm/H) | 9 (3.0–14.0) | 8 (4.0–11.3) | 12 (2.0–25.5) | 0.511 |
| D-dimer (ng/mL) | 530 (420–660) | 490 (390.0–567.5) | 580 (455.0–770.0) | 0.013* |
| Fibrinogen (g/L) | 2.88 (0.90) | 2.58 (0.68) | 3.26 (1.02) | 0.002* |
| Albumin (g/L) | 40.9 (3.60) | 41.80 (3.65) | 39.74 (3.22) | 0.018* |
| NLR | 2.42 (1.90–3.54) | 2.44 (1.94–3.67) | 2.36 (1.78–3.48) | 0.808 |
| LMR | 4.03 (2.99–5.34) | 3.95 (2.67–5.30) | 4.03 (3.28–5.60) | 0.903 |
| SII | 526.74 (293.6–761.50) | 522.06 (338.40–723.23) | 528.00 (288.46–875.58) | 0.923 |
| FAR | 6.50 (5.50–8.19) | 6.05 (5.15–6.88) | 7.36 (6.33–10.21) | 0.001* |
HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL, very low-density lipoprotein; CRP, C-reactive protein; ESR, Erythrocyte Sedimentation rate; NLR, neutrophil-to-lymphocyte ratio; LMR, lymphocyte-to-monocyte ratio; SII, systemic immune-inflammation index; FAR, fibrinogen-to-albumin ratio. *p–value < 0.05.
a
Missing data on C-reactive protein in 29 patients (42%).
b
Missing data on Erythrocyte Sedimentation rate in 30 patients (43%).